Physician profile
Thomas W Throckmorton
NPI 1740337625
$1,730,330.66
in general payments reported to CMS, 2019-2025
15 companies · $544K in 2025
The $544K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $58K · 2021: $125K · 2022: $212K · 2023: $341K · 2024: $389K · 2025: $544K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $900K · Consulting Fee: $312K · Education: $33K · Travel and Lodging: $25K · Food and Beverage: $4,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $899,819.01 |
| Consulting Fee | $312,188.75 |
| Education | $33,040.49 |
| Travel and Lodging | $25,384.73 |
| Food and Beverage | $4,377.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $1,103,835.21 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $591,549.42 | 2019-2025 | Comprehensive Glenoid, Comprehensive, Osseofit |
| Responsive Arthroscopy INC | $12,873.94 | 2021-2025 | Responsive Arthroscopy Devices, Responsive Arthroscopy Devices |
| Pacira Pharmaceuticals Incorporated | $11,331.25 | 2021-2025 | Exparel, Zilretta, Iovera |
| Medical Device Business Services, INC. | $3,510.00 | 2022 | |
| Osteocentric Technologies, INC. | $3,393.40 | 2020-2021 | |
| Anika Therapeutics, INC. | $2,629.08 | 2024-2025 | Hyaff, Hyalofast, Integrity |
| Depuy Synthes Products, INC. | $585.00 | 2022 | |
| Catalyst Orthoscience | $183.56 | 2024-2025 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
| Gentleman Orthopedic Solutions | $149.73 | 2023 | |
| Encore Medical, Lp | $127.17 | 2020 | |
| Depuy Synthes Sales INC. | $52.03 | 2020 | |
| Stryker Corporation | $43.06 | 2023 | Aequalis Ascend Flex |
| Smith+Nephew, INC. | $37.53 | 2024 | Aetos Shoulder System |
| Medacta USA, INC. | $30.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$129,038.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Throckmorton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.